A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL

Staiger, Annette M.; Altenbuchinger, Michael; Ziepert, Marita; Kohler, Christian; Horn, Heike; Huttner, Michael; Huettl, Katrin S.; Glehr, Gunther; Klapper, Wolfram; Szczepanowski, Monika; Richter, Julia; Stein, Harald; Feller, Alfred C.; Möller, Peter; Hansmann, Martin-Leo; Poeschel, Viola; Held, Gerhard; Loeffler, Markus; Schmitz, Norbert; Truemper, Lorenz; Pukrop, Tobias; Rosenwald, Andreas; Ott, German; Spang, Rainer; Siebert, Reiner; Pfreundschuh, Michael; Emed Demonstrator Project; German High Grade Non-Hodgkin's Ly

Erstveröffentlichung

2020

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Staiger, Annette M.

Altenbuchinger, Michael

Ziepert, Marita

Kohler, Christian

Horn, Heike

et al.

Institutions

UKU. Institut für Pathologie
UKU. Institut für Humangenetik

Published in

Leukemia ; 34 (2020), 2. - S. 543-552. - ISSN 0887-6924. - eISSN 1476-5551

Link to publication

https://dx.doi.org/10.1038/s41375-019-0573-y

Keywords

OF-ORIGIN CLASSIFICATION; GENE-EXPRESSION; ELDERLY-PATIENTS; REGULARIZATION PATHS; POOR-PROGNOSIS; HIGH-DENSITY; OPEN-LABEL; RITUXIMAB; PREDICTS; SURVIVAL

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record